About the Company

宁波毓昌生物技术有限公司于 2018 年 4 月在宁海设立,注册资本 2840 万元。公司基于多糖结合疫苗技术、毕赤酵母重组表达技术
和大肠杆菌重组表达技术三大技术平台专注于生物药的研发,包括人 用疫苗、重组蛋白和抗肿瘤药三大类产品。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,066.3812万(元)
Legal Representative: 胡栋
Date Established:
Credit Code: 91330226MA2AJ8X13H
Registered Address: 浙江省绍兴市越城区沥海街道云海路1号9-1号楼一层

People who follow this company also follow

Competitors (Similar Companies)

抗体 体外诊断试剂 诊断试剂 试剂
生物科技/生物工程 医用材料 细胞治疗 生物材料
偶联药物 药物研发 单克隆抗体药物 医药
科学研究 科研机构 研发 创客空间
药物研发 生物医疗 干细胞 再生医学
制药/药业 医药 抗生素 生物制剂
研发 化工科技 生物制品 生物医药
营养食品 大健康 研发 生产

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates